Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin

Descripción del Articulo

From its introduction in 1952 onwards, the clinical use of macrolides has been steadily increasing, both in human and veterinary medicine. Although initially designed to the treatment of Gram-positive microorganisms, this antimicrobial family has also been used to treat specific Gram-negative bacter...

Descripción completa

Detalles Bibliográficos
Autores: Gomes, C, Martinez-Puchol, S, Palma, N, Horna, G, Ruiz-Roldan, L, Pons, MJ, Ruiz, J
Formato: artículo
Fecha de Publicación:2017
Institución:Consejo Nacional de Ciencia Tecnología e Innovación
Repositorio:CONCYTEC-Institucional
Lenguaje:inglés
OAI Identifier:oai:repositorio.concytec.gob.pe:20.500.12390/1097
Enlace del recurso:https://hdl.handle.net/20.500.12390/1097
https://doi.org/10.3109/1040841X.2015.1136261
Nivel de acceso:acceso abierto
Materia:Mutaciones ribosomales
ARNr 23S
Metilasas
Esterasas
Fosfotransferasas
https://purl.org/pe-repo/ocde/ford#3.03.08
id CONC_b0a43f109bbc8d84694b2c864cec3fde
oai_identifier_str oai:repositorio.concytec.gob.pe:20.500.12390/1097
network_acronym_str CONC
network_name_str CONCYTEC-Institucional
repository_id_str 4689
dc.title.none.fl_str_mv Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
title Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
spellingShingle Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
Gomes, C
Mutaciones ribosomales
ARNr 23S
Metilasas
Esterasas
Fosfotransferasas
https://purl.org/pe-repo/ocde/ford#3.03.08
title_short Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
title_full Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
title_fullStr Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
title_full_unstemmed Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
title_sort Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin
author Gomes, C
author_facet Gomes, C
Martinez-Puchol, S
Palma, N
Horna, G
Ruiz-Roldan, L
Pons, MJ
Ruiz, J
author_role author
author2 Martinez-Puchol, S
Palma, N
Horna, G
Ruiz-Roldan, L
Pons, MJ
Ruiz, J
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Gomes, C
Martinez-Puchol, S
Palma, N
Horna, G
Ruiz-Roldan, L
Pons, MJ
Ruiz, J
dc.subject.none.fl_str_mv Mutaciones ribosomales
topic Mutaciones ribosomales
ARNr 23S
Metilasas
Esterasas
Fosfotransferasas
https://purl.org/pe-repo/ocde/ford#3.03.08
dc.subject.es_PE.fl_str_mv ARNr 23S
Metilasas
Esterasas
Fosfotransferasas
dc.subject.ocde.none.fl_str_mv https://purl.org/pe-repo/ocde/ford#3.03.08
description From its introduction in 1952 onwards, the clinical use of macrolides has been steadily increasing, both in human and veterinary medicine. Although initially designed to the treatment of Gram-positive microorganisms, this antimicrobial family has also been used to treat specific Gram-negative bacteria. Some of them, as azithromycin, are considered in the armamentarium against Enterobacteriaceae infections. However, the facility that this bacterial genus has to gain or develop mechanisms of antibiotic resistance may compromise the future usefulness of these antibiotics to fight against Enterobacteriaceae infections. The present review is focused on the mechanisms of macrolide resistance, currently described in Enterobacteriaceae.
publishDate 2017
dc.date.accessioned.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.available.none.fl_str_mv 2024-05-30T23:13:38Z
dc.date.issued.fl_str_mv 2017
dc.type.none.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12390/1097
dc.identifier.doi.none.fl_str_mv https://doi.org/10.3109/1040841X.2015.1136261
dc.identifier.isi.none.fl_str_mv 391856800001
url https://hdl.handle.net/20.500.12390/1097
https://doi.org/10.3109/1040841X.2015.1136261
identifier_str_mv 391856800001
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Critical Reviews in Microbiology
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.publisher.none.fl_str_mv Society of Tropical Medicine and Hygiene
publisher.none.fl_str_mv Society of Tropical Medicine and Hygiene
dc.source.none.fl_str_mv reponame:CONCYTEC-Institucional
instname:Consejo Nacional de Ciencia Tecnología e Innovación
instacron:CONCYTEC
instname_str Consejo Nacional de Ciencia Tecnología e Innovación
instacron_str CONCYTEC
institution CONCYTEC
reponame_str CONCYTEC-Institucional
collection CONCYTEC-Institucional
repository.name.fl_str_mv Repositorio Institucional CONCYTEC
repository.mail.fl_str_mv repositorio@concytec.gob.pe
_version_ 1839175672724979712
spelling Publicationrp01359500rp02997500rp01947500rp03118600rp02998500rp01161500rp01358400Gomes, CMartinez-Puchol, SPalma, NHorna, GRuiz-Roldan, LPons, MJRuiz, J2024-05-30T23:13:38Z2024-05-30T23:13:38Z2017https://hdl.handle.net/20.500.12390/1097https://doi.org/10.3109/1040841X.2015.1136261391856800001From its introduction in 1952 onwards, the clinical use of macrolides has been steadily increasing, both in human and veterinary medicine. Although initially designed to the treatment of Gram-positive microorganisms, this antimicrobial family has also been used to treat specific Gram-negative bacteria. Some of them, as azithromycin, are considered in the armamentarium against Enterobacteriaceae infections. However, the facility that this bacterial genus has to gain or develop mechanisms of antibiotic resistance may compromise the future usefulness of these antibiotics to fight against Enterobacteriaceae infections. The present review is focused on the mechanisms of macrolide resistance, currently described in Enterobacteriaceae.Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - ConcytecengSociety of Tropical Medicine and HygieneCritical Reviews in Microbiologyinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/4.0/Mutaciones ribosomalesARNr 23S-1Metilasas-1Esterasas-1Fosfotransferasas-1https://purl.org/pe-repo/ocde/ford#3.03.08-1Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycininfo:eu-repo/semantics/articlereponame:CONCYTEC-Institucionalinstname:Consejo Nacional de Ciencia Tecnología e Innovacióninstacron:CONCYTEC20.500.12390/1097oai:repositorio.concytec.gob.pe:20.500.12390/10972024-05-30 16:01:09.785https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_14cbinfo:eu-repo/semantics/closedAccessmetadata only accesshttps://repositorio.concytec.gob.peRepositorio Institucional CONCYTECrepositorio@concytec.gob.pe#PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE##PLACEHOLDER_PARENT_METADATA_VALUE#<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="9fd46273-b200-4c60-9607-8e61dcb5bc09"> <Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type> <Language>eng</Language> <Title>Macrolide resistance mechanisms in Enterobacteriaceae: Focus on azithromycin</Title> <PublishedIn> <Publication> <Title>Critical Reviews in Microbiology</Title> </Publication> </PublishedIn> <PublicationDate>2017</PublicationDate> <DOI>https://doi.org/10.3109/1040841X.2015.1136261</DOI> <ISI-Number>391856800001</ISI-Number> <Authors> <Author> <DisplayName>Gomes, C</DisplayName> <Person id="rp01359" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Martinez-Puchol, S</DisplayName> <Person id="rp02997" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Palma, N</DisplayName> <Person id="rp01947" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Horna, G</DisplayName> <Person id="rp03118" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Ruiz-Roldan, L</DisplayName> <Person id="rp02998" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Pons, MJ</DisplayName> <Person id="rp01161" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> <Author> <DisplayName>Ruiz, J</DisplayName> <Person id="rp01358" /> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <DisplayName>Society of Tropical Medicine and Hygiene</DisplayName> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by-nc-nd/4.0/</License> <Keyword>Mutaciones ribosomales</Keyword> <Keyword>ARNr 23S</Keyword> <Keyword>Metilasas</Keyword> <Keyword>Esterasas</Keyword> <Keyword>Fosfotransferasas</Keyword> <Abstract>From its introduction in 1952 onwards, the clinical use of macrolides has been steadily increasing, both in human and veterinary medicine. Although initially designed to the treatment of Gram-positive microorganisms, this antimicrobial family has also been used to treat specific Gram-negative bacteria. Some of them, as azithromycin, are considered in the armamentarium against Enterobacteriaceae infections. However, the facility that this bacterial genus has to gain or develop mechanisms of antibiotic resistance may compromise the future usefulness of these antibiotics to fight against Enterobacteriaceae infections. The present review is focused on the mechanisms of macrolide resistance, currently described in Enterobacteriaceae.</Abstract> <Access xmlns="http://purl.org/coar/access_right" > </Access> </Publication> -1
score 13.448538
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).